Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Fermentalg SA (0QTJ) AI Stock Analysis

GB:0QTJ

Fermentalg SA

(LSE:0QTJ)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue ExpansionSubstantial revenue expansion indicates that Fermentalg is gaining commercial traction for its microalgae-based ingredients. Continued top-line growth can improve operating leverage, support greater production scale, and strengthen the company’s ability to convert its specialized platform into a broader revenue base.
Negative Factors
Persistent UnprofitabilityFermentalg has not yet scaled its operations sufficiently to cover its cost base, despite revenue growth and better gross margins. Persistent operating and net losses weaken internal funding capacity and make the longer-term value of commercial expansion dependent on a successful profitability inflection.

Fermentalg SA (0QTJ) vs. iShares MSCI United Kingdom ETF (EWC)

-30%-20%-10%0%10%20%30%GB:0QTJ-20.08%EWC+23.59%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 46.73M
Dividend Yield
―
Average Volume (3M)
106
Price to Earnings (P/E)
-4.5
Beta (1Y)
0.77
Revenue Growth
3.22%
EPS Growth
24.05%
Country
UK
Employees
62
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

Fermentalg SA Business Overview & Revenue Model

Company Description

Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve various i...

Fermentalg SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

GB:0QTJ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:ALPATFR:ALPAT60NeutralEUR 4.04M6.98――-40.95%-39.70%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
FR:ALVALFR:ALVAL38UnderperformEUR 22.31M-2.13-87.66%―183.47%57.15%

* Healthcare Sector Average

Performance Comparison

-50%0%50%GB:0QTJFR:ALVALFR:ALPATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:0QTJ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0QTJFermentalg SA0.39-0.10-20.73%
FR:ALVALValbiotis SA0.630.034.84%
FR:ALPATPlant Advanced Technologies SA3.56-4.96-58.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.